Cadrenal Therapeutics, Inc Common Stock
Price & Volume
Stats
See more52W Range | $1.86-$14.64 |
Market Cap | $6.9M |
Shares Short | 55,656 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$5.59 |
News
See moreYahoo Finance • 24 days ago
Weekly Buzz: NVS, MRK Win FDA Nod; LLY Snaps Up ATAI; MANE Shines On Hair Loss Data
Yahoo Finance • last month
Cadrenal Therapeutics Announces up to $8.8 Million Private Placement Priced At-The-Market Under Nasdaq Rules
Yahoo Finance • 2 months ago
Cadrenal Therapeutics to File for FDA Rare Pediatric Disease Designation for Tecarfarin in Kawasaki Disease
About
CEO | Mr. Quang X. Pham |
CFO | Mr. John P. Sharp CPA |
Address | 822 A1A North, Ponte Vedra, FL, United States, 32082 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 5 |